Clinical trials for Kidney cancer
118 currently recruiting clinical trials
Looking for clinical trials?
Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:
- Create your account
- Copy-paste your latest medical report
- Our AI-based assistant does the rest for you
Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:
Phase 1 / Phase 2
Breast cancer
Lung cancer
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
Bladder / Urinary Tract / Urethral cancer
Stomach and esophageal cancer
Endometrial cancer
Ovarian / Fallopian tubes / Peritoneum cancer
#NCT05875168
#2023-507937-14-00
Locally Advanced
Metastatic
Metastatic Castration-resistant
1
2
3 or more
Systemic Treatment-Naive
6 recruiting sites
Daiichi Sankyo
Phase 1 / Phase 2
Breast cancer
Lung cancer
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
Bladder / Urinary Tract / Urethral cancer
Stomach and esophageal cancer
Endometrial cancer
Ovarian / Fallopian tubes / Peritoneum cancer
#NCT05410145
#2023-508517-16-00
Locally Advanced
Metastatic
Metastatic Castration-resistant
KRAS G12C
1
2
3 or more
Systemic Treatment-Naive
4 recruiting sites
D3 Bio (Wuxi) Co., Ltd
Phase 1 / Phase 2
Lung cancer
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
Bladder / Urinary Tract / Urethral cancer
Stomach and esophageal cancer
Endometrial cancer
Ovarian / Fallopian tubes / Peritoneum cancer
#NCT06726148
#2024-517281-42-00
Phase I - cancer amplifié CCNE1
Locally Advanced
Metastatic
Other mutation
1
2
3 or more
Systemic Treatment-Naive
2 recruiting sites
Novartis
Phase 1 / Phase 2
Breast cancer
Lung cancer
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
Bladder / Urinary Tract / Urethral cancer
Stomach and esophageal cancer
Endometrial cancer
Ovarian / Fallopian tubes / Peritoneum cancer
#NCT06669117
#2024-512760-64-00
Partie 1 (Escalade de dose)
Locally Advanced
Metastatic
Metastatic Castration-resistant
MET
1
2
3 or more
Systemic Treatment-Naive
4 recruiting sites
Laboratoires Pierre Fabre
Phase 1 / Phase 2
Breast cancer
Lung cancer
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
Bladder / Urinary Tract / Urethral cancer
Stomach and esophageal cancer
Endometrial cancer
Ovarian / Fallopian tubes / Peritoneum cancer
#NCT06188702
#2025-521249-25-00
Phase 1 Dose Escalation
Locally Advanced
Metastatic
MTAP
1
2
3 or more
Systemic Treatment-Naive
4 recruiting sites
Servier
Phase 1 / Phase 2
Breast cancer
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
Kidney cancer
Bladder / Urinary Tract / Urethral cancer
Endometrial cancer
Ovarian / Fallopian tubes / Peritoneum cancer
#NCT06188702
#2025-521249-25-00
Cohort Basket - autres tumeurs
Locally Advanced
Metastatic
MTAP
1
2
3 or more
Systemic Treatment-Naive
4 recruiting sites
Servier
Phase 1 / Phase 2
Kidney cancer
#NCT07049926
#2024-516437-12-00
Clear cell carcinoma
Locally Advanced
Metastatic
None
Immunotherapy
Systemic Treatment-Naive
5 recruiting sites
Merck Sharp & Dohme LLC
Phase 1 / Phase 2
Kidney cancer
#NCT05706129
#2023-504254-35-00
Other
Localized
None
Systemic Treatment-Naive
8 recruiting sites
Debiopharm International SA
Phase 1 / Phase 2
Kidney cancer
#NCT05706129
#2023-504254-35-00
Clear cell carcinoma
Locally Advanced
Metastatic
2
3 or more
Targeted therapy
Immunotherapy
Targeted therapy
8 recruiting sites
Debiopharm International SA
Phase 1
Breast cancer
Lung cancer
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
Bladder / Urinary Tract / Urethral cancer
Stomach and esophageal cancer
Endometrial cancer
Ovarian / Fallopian tubes / Peritoneum cancer
#NCT06220864
#2025-520557-36-00
Escalade et extension de dose monothérapie et escalade de dose combinaison
Locally Advanced
Metastatic
Metastatic Castration-resistant
1
2
3 or more
Systemic Treatment-Naive
4 recruiting sites
Synnovation Therapeutics, Inc.